CytoDyn Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
CytoDyn Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q3 2010 to Q3 2024.
  • CytoDyn Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending August 31, 2024 was $9.67M, a 141% increase year-over-year.
  • CytoDyn Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $11.7M, a 60.7% decline from 2022.
  • CytoDyn Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $29.9M, a 37.7% decline from 2021.
  • CytoDyn Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $48M, a 65% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $9.67M +$5.65M +141% Jun 1, 2024 Aug 31, 2024 10-Q 2024-10-15
Q3 2023 $4.02M -$7.5M -65.1% Jun 1, 2023 Aug 31, 2023 10-Q 2024-10-15
Q3 2022 $11.5M +$7.17M +165% Jun 1, 2022 Aug 31, 2022 10-Q 2023-10-23
Q3 2021 $4.35M -$40.6M -90.3% Jun 1, 2021 Aug 31, 2021 10-Q/A 2022-10-13
Q3 2020 $44.9M +$31.4M +232% Jun 1, 2020 Aug 31, 2020 10-Q 2021-10-12
Q3 2019 $13.5M +$1.03M +8.27% Jun 1, 2019 Aug 31, 2019 10-Q 2020-10-09
Q3 2018 $12.5M +$6.32M +102% Jun 1, 2018 Aug 31, 2018 10-Q 2019-10-08
Q3 2017 $6.17M Jun 1, 2017 Aug 31, 2017 10-Q 2018-10-09
Q3 2013 $880K +$687K +357% Jun 1, 2013 Aug 31, 2013 10-Q 2013-10-15
Q3 2012 $193K Jun 1, 2012 Aug 31, 2012 10-Q 2013-10-15
Q3 2010 $20.2K* Jun 1, 2010 Aug 31, 2010 10-Q/A 2011-11-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.